2011
DOI: 10.1016/j.tox.2011.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood–brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 41 publications
1
13
0
Order By: Relevance
“…In addition, the protein levels of MMP-9 and its endogenous inhibitor TIMP-1 didn't change significantly after EMP exposure. These data suggested that EMP exposure could increase the protein level of MMP-2, but had no effect on MMP-9, TIMP-1 and TIMP-2 in the BBB model, which was consistent with our previous study in vivo (Qiu et al, 2011).…”
Section: Electromagnetic Biology and Medicinesupporting
confidence: 92%
See 2 more Smart Citations
“…In addition, the protein levels of MMP-9 and its endogenous inhibitor TIMP-1 didn't change significantly after EMP exposure. These data suggested that EMP exposure could increase the protein level of MMP-2, but had no effect on MMP-9, TIMP-1 and TIMP-2 in the BBB model, which was consistent with our previous study in vivo (Qiu et al, 2011).…”
Section: Electromagnetic Biology and Medicinesupporting
confidence: 92%
“…Further study showed that the decrease of the TJ protein ZO-1 level resulted from the increased activity of gelatinase after EMP exposure (Qiu et al, 2011). To further explore the mechanism of EMP-induced BBB permeability change, especially the role of gelatinase in this process, we established the BBB model in vitro, and observed the protein level and activity of gelatinase.…”
Section: Electromagnetic Biology and Medicinementioning
confidence: 99%
See 1 more Smart Citation
“…This dose has been shown to be effective against both gelatinases in vivo. SB-3CT has been used in vivo at concentrations ranging from 5 to 25 mg/kg [29, 3335]. In our study, SB-3CT (25 mg/kg/day, i.v.)…”
Section: Resultsmentioning
confidence: 99%
“…MMP-2, MMP-3, MMP-7 and MMP-9), which raises the possibility that MMP activity on these substrates can enhance the permeability of endothelial barriers by destroying these junctions [203-209]. Therefore, enhanced MMP levels in malaria might facilitate BBB leakage.…”
Section: Introductionmentioning
confidence: 99%